The NHS plans to train hundreds of pharmacy staff, expanding their ability to provide advanced clinical services and assume wider roles in dispensing medicines.
With a targeted launch in September, up to 840 pharmacy technicians can join in the training programme. The online modules will cover consultation skills,
therapeutics, clinical decision-making, assessment skills, and service improvement.
"Community pharmacies are pivotal in local communities, and this novel training scheme empowers them to extend their service offerings to a wider patient base,"
said Health Minister Neil O'Brien. "Through our investment in the workforce, we're bolstering the implementation of the Pharmacy First initiative with £645 million,
ensuring patients have access to expert assistance for various common ailments, including urinary tract infections and earaches."
NHS said the training will offer flexibility to align with the working schedules and prior experience of community pharmacy technicians. It will combine independent
online e-course study, educational supervision, and clinical skills training. Facilitated workshops will concentrate on enhancing clinical assessment skills and
applying knowledge and skills through case studies, practice activities, and group discussions.
The Royal Pharmaceutical Society (RPS) has announced the results of the elections to vacant positions on the RPS Scottish and English Country Boards that took
place at the meeting on June 18.
The Scottish Pharmacy Board elected Jonathan Burton, FRPharmS, as their new Chair and Audrey Thompson to the RPS Assembly, the organisation's governing body.
Jonathan is a community pharmacist and an independent prescriber affiliated with the Right Medicine Pharmacy group in Stirling. He has played an integral role in
the inception, development and delivery of Pharmacy First services in Scotland.
He is an RPS Fellow and received an MBE in 2018 for services to healthcare. Jonathan is also the recipient of the 2023 RPS Charter Award. He previously served as
Chair of the Scottish Pharmacy Board from 2019 to 2021.
"Serving as Chair is a great privilege," said Jonathan while expressing his delight at being elected as the Chair of the Scottish Pharmacy Board.
Alitam Group, the 100-plus pharmacy store consolidation, has appointed Bharti Patel, the former group executive director of Avicenna to its executive board.
Patel, who was part of the leadership team at Avicenna until late 2021, brings with her a wealth of experience covering pharmaceuticals, multiple retail and independent pharmacy, homecare and NHS primary and secondary care.
In her early career, she worked at Lloyds Pharmacy, where she rose from a prescription medicines buyer to director of procurement over a period of eight years.
She is known in the industry for her strong leadership, commercial acumen and ability to create opportunities for innovation and strategic partnerships.
Alitam founder and CEO Feisal Nahaboo said in a statement that Patel's appointment will further strengthen the group's ability to deliver its transformative multi-billion-pound 'Pharmacy of the Future' concept.
National Pharmacy Association (NPA) has appointed Nick Kaye as its new chair on Monday (24 April).
He has taken over the chairmanship from Andrew Lane, who stood down last month after serving his maximum term.
Nick, who part-owns Hendra Pharmacy in Cornwall will serve for two years as NPA chair, after being elected unopposed at the first meeting of the new NPA board.
Jay Badenhorst, Managing Director and Superintendent Pharmacist for Whitworth Chemists in the North East of England, is now vice-chair.
Michael Guerin, the Managing Director and Superintendent Pharmacist of the Medicare group in Northern Ireland, continues as Treasurer.
Nick Kaye said: "As a third generation community pharmacist, I feel very privileged to serve the sector that I love so dearly in this way.
"Andrew will be a hard act to follow. But I can promise my unwavering commitment to independent community pharmacy, with Jay and Michael's 's support, plus that
of board colleagues and our dedicated executive team.
Asian Media Group will hold the inaugural Pharmacy Business Diversity Conference on Thursday December 9 - a ground-breaking event exploring and showcasing
diversity and inclusion in the pharmaceutical industry.
The conference, themed 'Change the Ratio', will be be chaired by BBC presenter Clive Myrie and held virtually between 10am and 5pm.
While both both RPS and ABPI are supporting the conference as associate sponsors, Well Pharmacy, the UK's largest independent pharmacy chain, is the headline sponsor
of the event that will have some of Britain's most inspiring leaders and influential diversity and inclusion practitioners.
These leaders will share their knowledge and experience whilst offering tangible steps to positively promote and implement diversity, inclusion and equality in workplace.
Check pharmacy business website for more information.
Pharmacy sales specialist, Hutchings Consultants has revealed its market predictions for the next 12 months in a new report.
The broker is anticipating that both independent group operators and corporate owners will continue to reassess their existing portfolios in 2024, making strategic
disposals of varying sizes.
"This is likely to result in transaction volumes remaining high for the foreseeable future," stated the report authored by Paul Steet, Associate Director, Hutchings
Consultants.
Community Pharmacy Contractual Framework negotiations will be the most notable opportunity for the sector to capitalise upon this year, the broker said, adding that
it's "a belated opportunity for the sector to secure a vital uplift to the contract's fixed global sum."
Medipharmacy has been bought out by PI-Gen Pharma Limited, an arm of the independent pharmacy group Enimed, for a total of £7.1 million, after the
business entered into administration.
In a report published on Companies House on January 30, administrators at FRP confirmed that the transaction was completed on 18 January, with PI-Gen beating
five other bidders to acquire the insolvent NHS pharmacy chain.
The report added that PI-Gen submitted a cash offer of non-refundable £500k for Medipharmacy's goodwill, £2.1m for its freehold properties, and a further amount
for its fixtures and fittings, motor vehicles and stock.
An FRP spokesperson told The Standard that Medipharmacy, which operated a chain of 25 NHS community pharmacies across London, Kent, Surrey and West Sussex, had
faced increasing cashflow challenges in recent months.
According to the administrators' report, Medipharmacy's revenues had grown exponentially from £27.9m in 2022 to £69m in 2023 but didn't deliver corresponding
improvements in profitability.
Talk of hub and spoke models has been rumbling on for as long as I can remember. The topic has once again hit the headlines as the government announced a
fresh consultation for its proposed changes, calling on all interested parties to submit their views by 8th June.
The argument for hub and spoke is to allow independents to have the same level playing field as the larger groups who have been operating this model for some time.
The government also sees significant efficiency gains in centralisation, arguing this will free pharmacists time away from dispensing to focus on clinical services.
The latest consultation advocates two models being created. In the first model, the dispensed medication is sent back to the spoke. In the second model, the completed
medication can be sent out directly to the patient.
The latter is a new concept which could open up new opportunities in how services are delivered. Pharmacies could effectively outsource the entire dispensing and
delivery to housebound patients and care homes allowing pharmacies to take on new business without having to worry about logistics and geography.
When I was asked by fellow independent contractors to join the Review Steering Group (RSG) back in late 2020, I said yes, because I wanted, fundamentally,
to look for some ways to improve both LPCs and PSNC. Through my experiences with Greater Manchester LPC I had seen the sorts of changes that LPCs could make and
the positive impact that those had on local engagement and in allowing us to do more to support contractors: I wanted to help share what we had learned with the
rest of the country. I was pretty sure that the national negotiator could make some positive changes as well.
It took longer than I had hoped. And it was a lot harder than I had imagined - not least because of the extent of some of the divisions within our sector - but
after 15 months of hard work, I'm pleased with where we have got to, and I believe the 37 changes being proposed will help all contractors.
Consensus is not a sexy word. It is not something that fires up our imaginations or that we put on our list of key work objectives for the year. It is also not something that might come naturally to us as independent contractors. But consensus is something that matters. It is the thing that allows us, as a vibrant and diverse group of businesses, to see beyond our differences and to fight together for outcomes that benefit every single one of us.
Consensus is also the thing that the RSG has been relentlessly focused on throughout its work, and it's at the heart of what will give our LPCs and PSNC a stronger voice for community pharmacy in the future.
The National Pharmacy Association (NPA) is asking independents to vote 'yes' to reform of pharmacy representation in England as a three-week voting period opens on Friday, May 27.
The NPA is also calling on PSNC to complete unfinished business and present 'the compelling case for change' that the Review Steering Group was unable to deliver.
The Associations says it is "on balance" and with some degree of reluctance supporting an affirmative vote, because the benefits marginally outweigh the several valid arguments for a "no" vote.
NPA chief executive, Mark Lyonette, said on Thursday (May 19): "After much deliberation and engagement with members, we are recommending our members vote yes, because the alternatives are either the flawed status quo or a further period of uncertainty for the sector, with months or even years of introspection to come. There is no guarantee that going back to the drawing board, particularly with the same actors, would bring about a better outcome.
Jhoots Group, a West Midlands based independent community pharmacy chain, has unveiled plans to expand its digital services after securing a funding worth
£8.23m from HSBC bank.
The new money will allow the groups branches to offer a digital platform for customers to request prescriptions online, enabling the implementation of a hub and
spoke dispensing system to automate prescription deliveries.
The innovation aims to reduce the burden of manual processes on pharmacists, allowing staff to use their time efficiently and support the NHS by offering vaccines
and minor ailment medicine services.
San Jhooty, chief operating officer at Jhoots Group, said: "When faced with the unprecedented challenges of the pandemic, primary and community services came
together to support the community and each other.
The Pharmacists' Defence Association (PDA) has called on pharmacy employers and pharmacists organisations to make donations towards the Pharmacist Support charity in the new year.
The association has urged them to donate £1 per pharmacist employee or member to the charity group to increase its funding from 2022 onwards.
Pharmacist Support, an independent charity, provides a variety of support services to pharmacists and their families, former pharmacists and pharmacy students in Great Britain.
It provides support through twelve sessions of fully funded counselling topharmacists, students, or trainees.
Since 2018, the association has donated more than £150,000 to the charity, in turn supporting its members who additionally seek assistance from Pharmacist Support.
The General Pharmaceutical Council (GPhC) has announced that the new requirement for independent prescribing courses will be applicable from 1st of October 2022.
Pharmacists currently taking independent prescribing courses and those who apply before 1 October won't be affected by the changes.
The new guidance was agreed at the council meeting on 8 September and went to the initial education and training Advisory Group on 22 September where it was well
received, the GPhC said.
"The guidance is now being finalised to reflect the discussions at the Council meeting and the initial education and training advisory group and will be published
in October."
The new guidance is relevant for both course providers and applicants and gives some specific suggestions and examples of what we may expect. It will support
consistency in the way education providers applied the new standards and will help individual pharmacists to understand the relevant experience they would need
before enrolling on a course.
Independent charity group, Pharmacist Support has appointed five new trustees to its board - David Downham, Karen Harrowing, Mohammed Hussain, Mala Khiroya, and Alison Scowcroft, for a term of three years.
The new recruits will join the existing Board members Anita Cawley, Catherine Harper, Paul Johnson, Steve Lutener, Esther Sadler-Williams, Mark Sweeney and Sarah Willis.
Harrowing, Downham and Hussain have begun their 3-year term in January 2022, while Scowcroft and Khiroya would join the board in June.
The new appointments are in line with the Charity's plans, announced last year, to enhance its volunteer schemes.
"Since the launch of the charity's new strategy in January 2020, the profession has been faced with many new challenges. We are really proud of the work we have done in the last few years to address some of these challenges," said Pharmacist Support chief executive Danielle Hunt.
The Royal Pharmaceutical Society has opened a survey which asks its members how they would want to take part in and learn about decisions made by the RPS.
The RPS said the survey was a core part of the independent review of member participation and communications led by communications consultancy Luther Pendragon.
It said: "We will be asking our members to join focus groups to give their opinions on how participation can be developed and strengthened, and how RPS communications
about decisions it has taken on behalf of the profession through its governance boards can be improved. We will also be asking our elected members and key external
stakeholders for their views over the coming weeks."
The Luther team will then build a series of recommendations for RPS and develop a corporate communications strategy which will include action plans to enable greater
participation.
RPS president Claire Anderson said: "We want to hear from as many of you as possible through our survey to inform how the organisation works with and engages with you,
our members.
ECG has launched a new 'simple and straightforward' Patient Group Direction (PGD) service for pharmacists working in primary care, together with a service
which offers direct access to an NHS Consultant for medical advice to offer robust safeguarding as and when needed.
Taking on more clinical services with the PGDs can feel daunting and a big responsibility for healthcare professionals. ECG's new medical advice service (for anyone
purchasing their PGDs) will offer pharmacists the opportunity to call and speak to a clinical member of the ECG team who will triage the calls and support them.
If required, the call will be connected to an experienced NHS Consultant to offer immediate medical advice. The service will start with a Monday-Friday 08:30-16:30hrs
provision with an option to increase to 24 /7 for those working out of hours. This is inclusive in the PGD pricing offer.
ECG has been the market leader in providing vaccination training to pharmacists since 2004, providing robust knowledge and clinical skills to enable pharmacists to
develop their private and NHS commissioned vaccination services (such as flu and covid). By developing their close working relationship with all of the multiples,
many smaller chains, membership groups and independents over the years, ECG has continued to further consolidate their 'one stop shop' approach to supporting the
sector.
ECG wants to offer this sector choices in the level of guidance and support that the individual healthcare professionals feel they need to offer safe care to
patients.
The Independent Pharmacies Association (IPA), in collaboration with the Association of Optometrists (AOP), the British Dental Association (BDA) and the
NHS Confederation has written to health secretary Wes Streeting, urging him to ensure sustainable investment in primary care to strengthen the NHS and better
serve patients.
In their letter, the group congratulated Streeting on his recent appointment as Secretary of State for Health and Social Care and requested a meeting to provide
their joint constructive input towards improving health outcomes.
They expressed concern that recent administrations have failed to follow through on promises to properly integrate and fund primary care, leading to deteriorating
health outcomes.
"Our collective experience is that our National Health Service (NHS), and health outcomes generally, have suffered at the hands of recent administrations that have
talked much about the importance of properly integrating and funding primary care but not followed through with action," they wrote.
The associations emphasised the need to transition the NHS to a Neighbourhood Health Service, where more care is delivered within local communities to identify
problems earlier.
The Royal Pharmaceutical Society (RPS) has published a new professional guidance for prescribing practice on Monday (June 6) which it says will be "for the
benefit of all independent prescribers across the UK".
Based on collaboration with multi-professional stakeholders, the document is a guidance tool for prescribers wanting to expand their prescribing scope of practice.
Commissioned by the Welsh government, the document was developed through an expert group with representatives from many healthcare professions, including from Higher Education institutions, professional bodies, regulatory bodies, the National Institute for Health and Care Excellence, NHS Education for Scotland, Health Education
and Improvement Wales, and representatives from hospital, community and GP practice.
RPS president Claire Anderson said: "It's fantastic to see the growth in prescribing, both across the profession and more widely, to improve patient care.
The government has accepted the Joint Committee on Vaccination and Immunisation's (JCVI) advice for the autumn 2024 COVID-19 vaccination programme.
According to the JCVI, the following groups will be eligible for vaccination this autumn:
Individuals aged 65 and over
Residents of care homes for older adults
Those aged 6 months and older in clinical risk groups
Minister for Public Health and Prevention, Andrew Gwynne, emphasised the importance of protecting vulnerable populations from COVID-19 and reducing pressure on
the NHS.
He said: "We are committed to protecting those most vulnerable from COVID and have accepted the independent advice from the JCVI for the autumn 2024 vaccination
programme."
"I encourage anyone invited for a vaccine to get one as soon as possible to protect yourself and reduce pressure on the NHS during winter, helping to cut waiting
times and get the health service back on its feet."
Recognising the changing practices in healthcare, the Royal Pharmaceutical Society (RPS) has revised and updated its position on the separation of
prescribing and dispensing or administration of a medicine by the same healthcare professional.
It's previous guidance, published in March 2020, restricted prescribing and dispensing by the same healthcare professional only in exceptional circumstances.
The new guidance, jointly developed with the Royal College of Nursing (RCN), has made prescribing and dispensing of medicines more flexible.
It clarifies that "where there is a risk assessment in place and in the best interests of the patient, the same healthcare professional can be responsible for
the prescribing and dispensing / supply / administration of medicines."
The change in the position statement follows an extensive year-long engagement exercise with medical associations, members, fellows, expert advisory groups,
patient groups and the RPS Country Boards.